Published in Z Gesamte Inn Med on January 01, 1969
[Systemic effects of ultraviolet, visible and infrared radiation in serial whole body irradiation. I. Oxygen utilization, flow properties of blood, hemodynamics, blood components and phagocytosis]. Dermatol Monatsschr (1989) 1.40
[Determination of the antinuclear factors in lupus erythematosus]. Dermatol Wochenschr (1965) 1.06
[On the behavior of glucose-6-phosphate dehydrogenase in the serum and erythrocytes of subjects with psoriasis]. Arch Klin Exp Dermatol (1967) 0.97
[Photochemotherapy of psoriasis using 8-methoxypsoralen and UVA. II. Binding of the photosensitizator to protein]. Dermatol Monatsschr (1976) 0.93
[Characteristics of psoriasis in childhood]. Dermatol Monatsschr (1979) 0.92
[Antinuclear factors in psoriasis vulgaris. (Preliminary report)]. Dermatol Wochenschr (1965) 0.91
[Pathogenesis and nosologic status of psoriatic arthropathy]. Hautarzt (1971) 0.89
[Immunologic and clinical studies on psoriasis]. Dtsch Gesundheitsw (1966) 0.89
Stable lipid peroxidation products in human skin: detection, ultraviolet light-induced increase, pathogenic importance. Experientia (1976) 0.88
[Photochemotherapy with 8-methoxypsoralen and UVA. III. Fluorescent microscopy studies of binding and transport of 8-MOP in the human skin]. Dermatol Monatsschr (1977) 0.87
High-dose UVA1 therapy for atopic dermatitis: results of a multicenter trial. J Am Acad Dermatol (1998) 0.86
Anti-endothelial antibodies in Takayasu arteritis. Arthritis Rheum (1994) 0.85
[Electron microscopy studies in lichen sclerosus and antrophicus]. Dermatol Monatsschr (1972) 0.85
[Studies on the excretion of tryptophan metabolites in patients with circumscript and progressive scleroderma]. Dermatol Wochenschr (1968) 0.85
[Abnormal HLA-DR antigen expression in monocytes of patients with systemic lupus erythematosus and psoriasis vulgaris]. Dermatol Monatsschr (1985) 0.84
[Selected ultraviolet phototherapy (SUP) with fluorescent bulbs in psoriasis vulgaris. II. Effect on immune complexes, DNA antibodies and T cells in vivo]. Dermatol Monatsschr (1983) 0.82
[The pathogenetic significance of "autoantibodies" in the NZB-W-F1 hybrids. II. Morphological studies]. Acta Biol Med Ger (1973) 0.82
[The lymphocyte transformation test in squamous epithelial carcinomas of the orofacial region]. Zahn Mund Kieferheilkd Zentralbl (1977) 0.82
[Clinical and physiopathological findings in lichen sclerosus et atrophicus]. Arch Klin Exp Dermatol (1968) 0.81
[Lymphocyte transformation test in bullous dermatoses]. Dermatol Monatsschr (1977) 0.81
[Studies on the pathogenesis of acrodermatitis enteropathica Danbolt-Closs]. Arch Klin Exp Dermatol (1967) 0.81
Effect of splenopentin (SP-5) on the antibody formation in immunosuppressed mice. Exp Clin Endocrinol (1986) 0.81
Detection of interferon in the sera of patients with psoriasis, and its enhancement by PUVA treatment. Br J Dermatol (1983) 0.80
[Clinical manifestations and diagnosis of penicillin allergy and other penicillin side effects]. Dermatol Monatsschr (1969) 0.80
The influence of topical dermatological treatment modalities on epidermal Langerhans cells and contact sensitization in mice. Contact Dermatitis (1992) 0.80
[Immunological studies on the nosology of psoriasis arthropathica]. Allerg Asthma (Leipz) (1969) 0.80
[Differentiation of the antipsoriatic and phototoxic effectiveness of topical PUVA therapy]. Hautarzt (1986) 0.79
[Transitory acantholytic dermatosis (Grover) in an HIV infected patient]. Z Hautkr (1990) 0.79
[On the evidence of antinuclear factors in various forms fof psoriasis]. Arch Klin Exp Dermatol (1966) 0.79
[Stabilization of the erythrocyte membrane with UVA-irradiation using 8-methoxypsoralen]. Dermatol Monatsschr (1980) 0.79
[Epilepsy as an early symptom of lupus erythematosus]. Dermatol Wochenschr (1965) 0.79
[Liver involvement in erythropoietic protoporphyria]. Dermatol Monatsschr (1974) 0.78
Polyclonal B cell activation in the acute phase of systemic lupus erythematosus--aspects of pathogenic significance. J Invest Dermatol (1982) 0.78
[Inactivation and protection of phosphofructokinase during 8-methoxypsoralen and UVA-treatment]. Dermatol Monatsschr (1980) 0.78
[Destruction of peripheral lymphocytes by 8-MOP and UVA]. Dermatol Monatsschr (1980) 0.78
[On the problem of demonstration of antinuclear factors in scleroderma patients]. Dermatol Wochenschr (1966) 0.77
Anti-CENP-B response in sera of uranium miners exposed to quartz dust and patients with possible development of systemic sclerosis (scleroderma). J Rheumatol (1995) 0.77
[Familial studies in lupus erythematosus]. Dermatol Wochenschr (1965) 0.77
[Recent studies on antinuclear factors with special reference to differential diagnostic and genetic viewpoints]. Z Gesamte Inn Med (1967) 0.77
Comparison of the effects of calcipotriol, prednicarbate and clobetasol 17-propionate on normal skin assessed by ultrasound measurement of skin thickness. Skin Pharmacol (1994) 0.77
[Comparative studies of senstive chronaxy in various forms of scleroderma and lichen sclerosus et atrophicus]. Dermatol Wochenschr (1968) 0.77
[Electron microscopy studies on the demonstration of virus-like particles in dermatomyositis]. Dermatol Monatsschr (1973) 0.76
The influence of interferon-gamma, interleukin-2, prostaglandin E2, and cyclosporine on the polyclonal and anti-DNA antibody secretion in lymphocyte cultures derived from patients with systemic lupus erythematosus. Arch Dermatol Res (1987) 0.76
[Differential diagnostic studies on lupus erythematosus chronicus discoides and lymphocyte infiltration Jessner-Kanof using the immunofluorescent technic]. Arch Klin Exp Dermatol (1968) 0.76
Cis-urocanic acid as a mediator of ultraviolet-light-induced immunosuppression. Semin Hematol (1992) 0.76
[Electron microscopy studies of the muscles in lupus erythematosus]. Dermatol Monatsschr (1973) 0.76
[The role of immunofluorescence methods in dermatology (technic and clinical use)]. Dermatol Monatsschr (1970) 0.76
[Electron microscopy examinations of the muscular tissue in psoriasis arthropathica]. Dermatol Monatsschr (1971) 0.76
Studies on the effects of a high dose UVA-1 radiation therapy on surface markers and function of epidermal Langerhans cells. Arch Dermatol Res (1993) 0.76
Stimulation of the recruitment of epidermal Langerhans cells by splenopentin. Arch Dermatol Res (1990) 0.75
[Therapy of lupus erythematosus during pregnancy]. Dtsch Gesundheitsw (1969) 0.75
[The pathogenic significance of "autoantibodies" in NZB-W-F1 hybrids. 3. Immunohistological studies]. Acta Biol Med Ger (1973) 0.75
[Electron microscopic study of the bone marrow in chronic discoid and systemic lupus erythematosus]. Dermatol Monatsschr (1974) 0.75
[Studies on animal experiment models for the demonstration of sensitization potency of chemical combinations. II. Results after sensitization with cobalt chloride]. Dermatol Monatsschr (1973) 0.75
[Treatment of arthropathic psoriasis with antimetabolites and glucocorticoids]. Dermatol Monatsschr (1971) 0.75
[Allergic diseases of the skin]. Z Arztl Fortbild (Jena) (1971) 0.75
[Behavior of leukocytes and antileukocytic antibodies in lupus erythematosus]. Dermatol Wochenschr (1967) 0.75
[Studies on the increase of scabies. II. Clinical aspects and epidemiology of the current scabies epidemics]. Dermatol Monatsschr (1971) 0.75
[Comparative infrared determinations of the rewarming of the skin in endogenous and atopic eczema]. Dermatol Monatsschr (1971) 0.75
[External therapy at the Hospital for Dermatology in Berlin]. Dermatol Monatsschr (1974) 0.75
[Significance of scabies in childhood]. Padiatr Grenzgeb (1974) 0.75
[On the diagnosis of dermatomyositis]. Dtsch Gesundheitsw (1966) 0.75
[Evaluation of serologic methods for the determination of antinuclear factors and their differential-diagnostic significance]. Dtsch Gesundheitsw (1967) 0.75
[Comprehensibility of latent muscle participation in lupus erythematodes]. Dermatol Monatsschr (1974) 0.75
[Therapeutic possibilities in chronic connective tissue diseases in ambulatory and stationary care]. Dermatol Wochenschr (1967) 0.75
[75th birthday of Professor Dr. Dr. h. c. Karl Linser]. Przegl Dermatol (1971) 0.75
[Drug hypersensitivity in lupus erythematosus]. Allerg Asthma (Leipz) (1967) 0.75
[Studies on the kidney involvement in lupus erythematodes chronicus]. Dermatol Monatsschr (1970) 0.75
[Current penicillin therapy of syphilis from a critical viewpoint]. Z Arztl Fortbild (Jena) (1971) 0.75
[Photometric demonstration of antibodies against deoxyribonucleic acid using the Farr technic]. Dermatol Monatsschr (1974) 0.75
[Studies of muscle changes in chronic lupus erythematosus]. Arch Klin Exp Dermatol (1967) 0.75
[Current smallpox problems for the dermatologist]. Dermatol Monatsschr (1974) 0.75
[Rewarming, heat conduction ability and blood circulation of the skin in healthy subjects and scleroderma patients]. Dermatol Monatsschr (1974) 0.75
[Basic principles of autoimmune diseases]. Dermatol Monatsschr (1969) 0.75
[Studies on the currently increased incidence and on the clinical aspects and therapy of scabies]. Dtsch Gesundheitsw (1970) 0.75
[Studies on the demonstration and the transferability of cellular antibodies in drug-induced exanthema]. Dermatol Wochenschr (1967) 0.75
[Clinical and morphologic peculiarities in simultaneous occurrence of lupus erythematodes and exanthema from drugs]. Z Haut Geschlechtskr (1966) 0.75
[Measurement of skin temperature with the infra-red radiation measuring device by Kortum]. Dermatol Monatsschr (1969) 0.75
[Characteristics of an uniform definition and nomenclature of the eczema-group]. Dermatol Monatsschr (1973) 0.75
[Current knowledge on the pathogenesis of common psoriasis as the basis for a scientifically founded therapy. II. Therapeutic possibilities and pathogenetic principles of antipsoriatic drugs]. Dtsch Gesundheitsw (1970) 0.75
[Experiences with combined long term therapy of psoriasis arthropathica using antimetabolites and steroids]. Dermatol Monatsschr (1974) 0.75
[Muscle lipids in dermatomyositis, progressive scleroderma, allergic subsepsis, impetigo herpetiformis, chronic lupus erythematosus and psoriasis vulgaris]. Dermatol Monatsschr (1973) 0.75
[Present knowledge on the pathogenesis of common psoriasis as the basis for a scientifically founded therapy. I. Pathogenesis of common psoriasis]. Dtsch Gesundheitsw (1970) 0.75
[Impairment of DNA repair in xeroderma pigmentosa]. Dermatol Monatsschr (1973) 0.75
[Comparative immunological studies in lupus erythematosus, primary chronic polyarthritis and psoriasis arthropathica]. Allerg Asthma (Leipz) (1969) 0.75
[Autoimmunology studies in psoriasis patients]. Dermatol Monatsschr (1969) 0.75
[Tryptophan and tyrosine administration in acrodermatitis enteropathica (Danbolt)]. Klin Wochenschr (1967) 0.75
[Drug sensitization in lupus erythematosus patients]. Allerg Asthma (Leipz) (1967) 0.75
[Diagnostic criteria in lupus erythematosus with special reference to skin changes]. Dermatol Monatsschr (1971) 0.75
[On the pathogenesis of medicamentous exanthema]. Z Arztl Fortbild (Jena) (1967) 0.75
[Animal experiment studies on the determination of sensitivity capacity of chemical compounds. 3. Results following sensitization with dinitrochlorobenzene and final evaluation]. Dermatol Monatsschr (1974) 0.75
[Comparative studies of the diagnostic usefulness of the intracutaneous leukocyte test and antinuclear factors in chronic lupus erythematosus]. Z Haut Geschlechtskr (1967) 0.75
[Morphological and biochemical findings in multiple nevoxanthoendothelioma]. Hautarzt (1967) 0.75
[Present tasks and problems in the research of psoriasis]. Dermatol Monatsschr (1970) 0.75
[On the question of autoimmunization as the basis of the so-called collagenoses]. Z Gesamte Inn Med (1969) 0.75
[Is the post-therapeutic provocation test in gonorrhea justified?]. Dermatol Monatsschr (1973) 0.75
[Virus-like structures in the skin and kidneys of patients with chronic and visceral lupus erythematosus. Electron microscope study]. Vestn Dermatol Venerol (1974) 0.75
[Indications and contraindications for the interruption in dermatologic diseases (author's transl)]. Ther Umsch (1974) 0.75
[Lupus erythematodes in childhood--a virus-induced autoimmune disease?]. Padiatr Grenzgeb (1974) 0.75
[Current viewpoints on the pathogenesis of lupus erythematosus]. Z Arztl Fortbild (Jena) (1971) 0.75